Literature DB >> 11704645

Regulation of VEGF-induced endothelial cell PAF synthesis: role of p42/44 MAPK, p38 MAPK and PI3K pathways.

P N Bernatchez1, B G Allen, D S Gélinas, G Guillemette, M G Sirois.   

Abstract

1. Vascular endothelial growth factor (VEGF) is a potent angiogenic and inflammatory mediator. We have recently shown that this latter effect requires the activation of Flk-1 receptor and subsequent endothelial cell (EC) PAF synthesis. However, the intracellular events that regulate EC PAF synthesis upon Flk-1 stimulation by VEGF remain to be elucidated. 2. Using specific inhibitors and Western blot analysis, we herein report that in bovine aortic endothelial cells (BAEC), VEGF induces the synthesis of PAF through the cascade activation of Flk-1 receptor, phospholipase Cgamma (PLCgamma), protein kinase C (PKC) and p42/44 mitogen-activated protein kinases (MAPK). 3. Moreover, we demonstrate that VEGF-mediated PAF synthesis requires the activation of p38 MAPK, likely by directing the conversion of lyso-PAF to PAF. 4. Interestingly, we observed that VEGF also promoted the activation of the phosphatidyl inositol-3-phosphate kinase (PI3K) pathway, and that its blockade potentiated PAF synthesis following a VEGF treatment. Consequently, it appears that the PI3K pathway acts as a negative regulator of EC PAF synthesis. 5. Taken together, these results allow a better understanding of the intracellular events activated upon EC stimulation by VEGF, and shed a new light on the mechanisms by which VEGF induces PAF synthesis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11704645      PMCID: PMC1573057          DOI: 10.1038/sj.bjp.0704367

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  40 in total

1.  A rapid method of total lipid extraction and purification.

Authors:  E G BLIGH; W J DYER
Journal:  Can J Biochem Physiol       Date:  1959-08

2.  What is the evidence that tumors are angiogenesis dependent?

Authors:  J Folkman
Journal:  J Natl Cancer Inst       Date:  1990-01-03       Impact factor: 13.506

Review 3.  Angiogenic factors.

Authors:  J Folkman; M Klagsbrun
Journal:  Science       Date:  1987-01-23       Impact factor: 47.728

Review 4.  Platelet-activating factor.

Authors:  S M Prescott; G A Zimmerman; T M McIntyre
Journal:  J Biol Chem       Date:  1990-10-15       Impact factor: 5.157

5.  Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis.

Authors:  D T Connolly; D M Heuvelman; R Nelson; J V Olander; B L Eppley; J J Delfino; N R Siegel; R M Leimgruber; J Feder
Journal:  J Clin Invest       Date:  1989-11       Impact factor: 14.808

6.  The regulation of platelet-activating factor production in endothelial cells. The role of calcium and protein kinase C.

Authors:  R E Whatley; P Nelson; G A Zimmerman; D L Stevens; C J Parker; T M McIntyre; S M Prescott
Journal:  J Biol Chem       Date:  1989-04-15       Impact factor: 5.157

7.  Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid.

Authors:  D R Senger; S J Galli; A M Dvorak; C A Perruzzi; V S Harvey; H F Dvorak
Journal:  Science       Date:  1983-02-25       Impact factor: 47.728

8.  The bisindolylmaleimide GF 109203X is a potent and selective inhibitor of protein kinase C.

Authors:  D Toullec; P Pianetti; H Coste; P Bellevergue; T Grand-Perret; M Ajakane; V Baudet; P Boissin; E Boursier; F Loriolle
Journal:  J Biol Chem       Date:  1991-08-25       Impact factor: 5.157

9.  Demethoxyviridin and wortmannin block phospholipase C and D activation in the human neutrophil.

Authors:  R W Bonser; N T Thompson; R W Randall; J E Tateson; G D Spacey; H F Hodson; L G Garland
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

10.  Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells.

Authors:  E N Unemori; N Ferrara; E A Bauer; E P Amento
Journal:  J Cell Physiol       Date:  1992-12       Impact factor: 6.384

View more
  8 in total

1.  G protein-coupled receptors activate p38 MAPK via a non-canonical TAB1-TAB2- and TAB1-TAB3-dependent pathway in endothelial cells.

Authors:  Neil J Grimsey; Ying Lin; Rachan Narala; Cara C Rada; Hilda Mejia-Pena; JoAnn Trejo
Journal:  J Biol Chem       Date:  2019-02-13       Impact factor: 5.157

2.  Immediate and delayed VEGF-mediated NO synthesis in endothelial cells: role of PI3K, PKC and PLC pathways.

Authors:  David S Gélinas; Pascal N Bernatchez; Simon Rollin; Nicolas G Bazan; Martin G Sirois
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

3.  Inhibition of intrahepatic bile duct dilation of the polycystic kidney rat with a novel tyrosine kinase inhibitor gefitinib.

Authors:  Yasunori Sato; Kenichi Harada; Shinichi Furubo; Kazuo Kizawa; Takahiro Sanzen; Mitsue Yasoshima; Satoru Ozaki; Kumiko Isse; Motoko Sasaki; Yasuni Nakanuma
Journal:  Am J Pathol       Date:  2006-10       Impact factor: 4.307

4.  Signaling in TRPV1-induced platelet activating factor (PAF) in human esophageal epithelial cells.

Authors:  Jie Ma; Karen M Harnett; Jose Behar; Piero Biancani; Weibiao Cao
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-12-03       Impact factor: 4.052

5.  Upregulation of microRNA-205 suppresses vascular endothelial growth factor expression-mediated PI3K/Akt signaling transduction in human keloid fibroblasts.

Authors:  Gang An; Shuzeng Liang; Chunhong Sheng; Yan Liu; Wei Yao
Journal:  Exp Biol Med (Maywood)       Date:  2016-10-04

6.  Characterization of acetyl-CoA: lyso-PAF acetyltransferase of human mesangial cells.

Authors:  Elizabeth Fragopoulou; Christos Iatrou; Constantinos Alexandros Demopoulos
Journal:  Mediators Inflamm       Date:  2005-10-24       Impact factor: 4.711

7.  Autophagy inhibition contributes to Endostar sensitization in esophageal squamous cell carcinoma.

Authors:  Xinghua Han; Zhanggui Wang; Bin Hu; Jianming Xu
Journal:  Oncol Lett       Date:  2017-09-21       Impact factor: 2.967

Review 8.  Myoferlin, a multifunctional protein in normal cells, has novel and key roles in various cancers.

Authors:  Wei Zhu; Bolun Zhou; Chenxuan Zhao; Zhengqing Ba; Hongjuan Xu; Xuejun Yan; Weidong Liu; Bin Zhu; Lei Wang; Caiping Ren
Journal:  J Cell Mol Med       Date:  2019-09-01       Impact factor: 5.310

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.